A carregar...

Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum

Aberrant epigenetic modifications are an early event in carcinogenesis, with the epigenetic landscape continuing to change during tumor progression and metastasis—these observations suggest that specific epigenetic modifications could be used as diagnostic and prognostic biomarkers for many cancer t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Thomas, Margaret L., Marcato, Paola
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5923356/
https://ncbi.nlm.nih.gov/pubmed/29614786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers10040101
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!